feed,title,long_url,short_url
BioRxiv,Discovery of anti-SARS-CoV-2 molecules using structure-assisted repurposing approach targeting N-protein,https://biorxiv.org/cgi/content/short/2022.03.12.484092v1?rss=1,https://bit.ly/35Y2sTJ
BioRxiv,A broad and potent neutralization epitope in SARS-related coronaviruses,https://biorxiv.org/cgi/content/short/2022.03.13.484037v1?rss=1,https://bit.ly/35RID0v
BioRxiv,Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events,https://biorxiv.org/cgi/content/short/2022.03.13.484129v1?rss=1,https://bit.ly/3CH1p6w
BioRxiv,The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes,https://biorxiv.org/cgi/content/short/2022.03.12.484088v1?rss=1,https://bit.ly/3tPsf8o
BioRxiv,Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant,https://biorxiv.org/cgi/content/short/2022.03.13.484123v1?rss=1,https://bit.ly/37zrFo9
BioRxiv,Accelerating PERx Reaction Enables Covalent Nanobodies for Potent Neutralization of SARS-Cov-2 and Variants,https://biorxiv.org/cgi/content/short/2022.03.11.483867v1?rss=1,https://bit.ly/35RIKcr
